Requests similar to 'Trikafta Funding Announcement' (page 2)
Covid19 XBB Vaccine availability
Response by Pharmaceutical Management Agency to Daniel Richards on .
Information not held.
Kia ora Daniel
Please find a response to your request attached to this email.
Ngâ mihi,
Katy Carlson ([1]she/her) | Government Se...
Kia ora Chris
Please find a response to your request attached to this email.
Ngâ mihi,
Katy Carlson ([1]she/her) | Government Se...
Correspondence between Pharmac and NZMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Thank you for your email.
Your request has been received and logged. Our reference number for your
request is: 2021-22-016...
MoH criteria for Special Authority application of stimulant medication
Response by Pharmaceutical Management Agency to Cody C on .
Information not held.
Kia ora Cody
Please find a response to your request attached to this email.
Ngâ mihi,
Katy Carlson (she/her) | Government Services Advisor
________...
7 - ADHD Medicines, Funding, Access, and Equity
Response by Pharmaceutical Management Agency to Elspeth Baker-Vevers on .
Partially successful.
Kia ora Elspeth
Thank you for your request for official information, which Pharmac received on 2 December 2025. The reference number for your request...
Kia ora Simon
Thank you for your request for information, received by Pharmac on 5 February 2024. Your request has been received and logged. Our refer...
Kia ora Simon
Thank you for your request for information, received by Pharmac on 1 April 2024. Your request has been received and logged. Our referenc...
Immunosuppressed/diabetic/cancer populations - common associated conditions.
Response by Pharmaceutical Management Agency to J Bruning on .
Information not held.
Kia ora Jodie
Thank you for your request for information, received by Pharmac on 17 April 2024. Your request has been received and logged. Our referen...
Kia ora A Mark
Please find attached a response to your request for information regarding
funding decisions for Trikafta.
Ngā mihi
...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Services Adv...
Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora J
Thank you for your request for official information, which Pharmac received on . The reference number for your request is: 2025-26-042
You...
The total legal costs incurred by Pharmac in relation to proceedings: CIV-2024-404-845 – Whittome v Director-General of Health
Response by Pharmaceutical Management Agency to John Armstrong on .
Awaiting classification.
Tçnâ koe John Armstrong
This email acknowledges receipt of your Official Information Act (1982)
(OIA)request of 13 July 2026 to Pharmac for the...
Pharmac Budget Bids
Response by Pharmaceutical Management Agency to Jennifer Jiayi on .
Awaiting classification.
Kia ora Jennifer
Thank you for your request for official information, which Pharmac
received on 5 June 2025.
We are contacting you as your...
Maori Advisory Committee
Response by Pharmaceutical Management Agency to Alan Riley on .
Successful.
Kia ora Alan,
Please find attached a response to your Official Information Act request,
which was received on 13 November 2024.
Please con...
Review, analysis, or consideration of Pharmac' statuatory objective
Response by Pharmaceutical Management Agency to Jennifer Jiayi on .
Refused.
Kia ora Jennifer
Thank you for your request for official information, which Pharmac
received on 5 May 2025. The reference number for your reques...
Recent expenditure on Chemotherapy, Anticoagulants and Immunomodulaters
Response by Pharmaceutical Management Agency to Matthew Shelton on .
Successful.
Kia ora Matthew
Please accept our sincere apologies for missing some of the data in your
previous response
Please find attached the updated da...
Meeting notes and outcomes
Response by Pharmaceutical Management Agency to A L.C on .
Awaiting classification.
Kia ora A L.C
Thank you for your request for official information, which Pharmac received on 26 September 2024. The reference number for your request...
Discontinuation of Phenelzine Sulphare
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs,
Thank you for your request for official information, received by PHARMAC
on 23 April 2020.
Your request has been received and l...
Decision to delay Pump and CGM Funding for T1 Diabetics
Response by David Seymour to Fiona Smith on .
Awaiting classification.
Dear Fiona
Please find attached response to your OIA request of 29 May.
Kind regards, Annette
Annette Gratkowski | Private Secretary...
Numbers of prescriptions: Antidepressants Antipsychotics and ADHD medication/stimulants
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora J Bruning
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find a response for your request for information attached with this email.
Ngā mihi
Simon
Simon Mitchell | Senior Policy Adviso...
Cancer drugs v other drugs
Response by Pharmaceutical Management Agency to Brendon Mills on .
Successful.
Kia ora Brendon
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
_...
Shortage of prescribed medication Concerta
Response by Pharmaceutical Management Agency to gerald on .
Awaiting classification.
Kia ora Gerald
Apologies, the correct due date for your response is 4 June 2025.
Ngā mihi
Government Services | Pharmac
___________...
Approval of PHARMAC funded thyroid medications
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Good afternoon Belinda.
Please find attached our response to your request for PTAC minutes and the Endocrinology Subcommittee minutes that recommended...
Public knowledge of communication
Response by Pharmaceutical Management Agency to A L.C on .
Successful.
Kia ora
Please find attached a response to your request for official information.
Ngā mihi
Government Services | Pharmac
______...